Startseite Diagnosis and approach of pseudohypoparathyroidism type 1A and related disorders during long term follow-up: a case report
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Diagnosis and approach of pseudohypoparathyroidism type 1A and related disorders during long term follow-up: a case report

  • Mónica Expósito Raspeño ORCID logo EMAIL logo , Verónica Sánchez Escudero ORCID logo , Guiomar Pérez de Nanclares Leal ORCID logo , María Ortiz Santamaría ORCID logo , Rosa Sánchez-Dehesa Sáez ORCID logo , Beatriz García Cuartero ORCID logo und Amparo González Vergaz ORCID logo
Veröffentlicht/Copyright: 5. Februar 2024

Abstract

Objectives

Pseudohypoparathyroidism type 1A (PHP1A) encompasses the association of resistance to multiple hormones, features of Albright hereditary osteodystrophy and decreased Gsα activity. Little is known about the early signs of PHP1A, with a delay in diagnosis. We report two PHP1A cases and their clinical and biochemical findings during a 20-year follow-up.

Case presentation

Clinical suspicion was based on obesity, TSH resistance and ectopic ossifications which appeared several months before PTH resistance, at almost 3 years of age. Treatment with levothyroxine, calcitriol and calcium was required in both patients. DNA sequencing of GNAS gene detected a heterozygous pathogenic variant within exon 7 (c.569_570delAT) in patient one and a deletion from XLAS to GNAS-exon 5 on the maternal allele in patient 2. In patient 1, ectopic ossifications that required surgical excision were found. Noticeably, patient 2 displayed adult short stature, intracranial calcifications and psychomotor delay. In terms of weight, despite early diagnosis of obesity, dietary measures were established successfully in both cases.

Conclusions

GNAS mutations should be considered in patients with obesity, ectopic ossifications and TSH resistance presented in early infancy. These cases emphasize the highly heterogeneous clinical picture PHP1A patients may present, especially in terms of final height and cognitive impairment.


Corresponding author: Dra. Mónica Expósito Raspeño, Department of Pediatric Endocrinology, Severo Ochoa University Hospital, Orellana Avenue, No Number, Madrid, 28911, Spain, E-mail:

  1. Research ethics: Not applicable.

  2. Informed consent: Informed consent was obtained from all individuals included in this study.

  3. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Competing interests: Authors state no conflict of interest.

  5. Research funding: None declared.

References

1. Albright, F, Burnett, C, Smith, P, Parson, W. Pseudohypoparathyroidism: an example of Seabright-Bantam syndrome. Endocrinology 1942;30:922–32.Suche in Google Scholar

2. Del Sindaco, G, Berkenou, J, Pagnano, A, Rothenbuhler, A, Arosio, M, Mantovani, G, et al.. Neonatal and early infancy features of patients with inactivating PTH/PTHrP Signaling Disorders/Pseudohypoparathyroidism. J Clin Endocrinol Metab 2023;108:2961–9. https://doi.org/10.1210/clinem/dgad236.Suche in Google Scholar PubMed PubMed Central

3. Underbjerg, L, Sikjaer, T, Mosekilde, L, Rejnmark, L. Pseudohypoparathyroidism – epidemiology, mortality and risk of complications. Clin Endocrinol 2016;84:904–11. https://doi.org/10.1111/cen.12948.Suche in Google Scholar PubMed

4. Mantovani, G, Bastepe, M, Monk, D, de Sanctis, L, Thiele, S, Ahmed, SF, et al.. Recommendations for diagnosis and treatment of pseudohypoparathyroidism and related disorders: an Updated Practical Tool for Physicians and patients. Horm Res Paediatr 2020;93:182–96. https://doi.org/10.1159/000508985.Suche in Google Scholar PubMed PubMed Central

5. Mantovani, G, Bastepe, M, Monk, D, de Sanctis, L, Thiele, S, Usardi, A, et al.. Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement. Nat Rev Endocrinol 2018;14:476–500. https://doi.org/10.1038/s41574-018-0042-0.Suche in Google Scholar PubMed PubMed Central

6. Martin, J, Tucker, M, Browning, JC. Infantile osteoma cutis as a presentation of a GNAS mutation. Pediatr Dermatol 2012;29:483–4. https://doi.org/10.1111/j.1525-1470.2011.01469.x.Suche in Google Scholar PubMed

7. Fernández-Rebollo, E, García-Cuartero, B, Garin, I, Largo, C, Martínez, F, Garcia-Lacalle, C, et al.. Intragenic GNAS deletion involving exon A/B in pseudohypoparathyroidism type 1A resulting in an apparent loss of exon A/B methylation: potential for misdiagnosis of pseudohypoparathyroidism type 1B. J Clin Endocrinol Metab 2010;95:765–71. https://doi.org/10.1210/jc.2009-1581.Suche in Google Scholar PubMed PubMed Central

8. Mantovani, G. Clinical review: pseudohypoparathyroidism: diagnosis and treatment. J Clin Endocrinol Metab 2011;96:3020–30. https://doi.org/10.1210/jc.2011-1048.Suche in Google Scholar PubMed

9. Gelfand, IM, Eugster, EA, DiMeglio, LA. Presentation and clinical progression of pseudohypoparathyroidism with multi-hormone resistance and Albright hereditary osteodystrophy: a case series. J Pediatr 2006;149:877–80. https://doi.org/10.1016/j.jpeds.2006.08.050.Suche in Google Scholar PubMed

10. Mantovani, G, Linglart, A, Garin, I, Silve, C, Elli, FM, de Nanclares, GP. Clinical utility gene card for: pseudohypoparathyroidism. Eur J Hum Genet 2013;21. https://doi.org/10.1038/ejhg.2012.211.Suche in Google Scholar PubMed PubMed Central

11. Vigone, MC, Di Frenna, M, Guizzardi, F, Gelmini, G, de Filippis, T, Mora, S, et al.. Mild TSH resistance: clinical and hormonal features in childhood and adulthood. Clin Endocrinol 2017;87:587–96. https://doi.org/10.1111/cen.13387.Suche in Google Scholar PubMed

12. Liu, J, Erlichman, B, Weinstein, LS. The stimulatory G protein alpha-subunit Gs alpha is imprinted in human thyroid glands: implications for thyroid function in pseudohypoparathyroidism types 1A and 1B. J Clin Endocrinol Metab 2003;88:4336–41. https://doi.org/10.1210/jc.2003-030393.Suche in Google Scholar PubMed

13. Hanna, P, Grybek, V, Perez de Nanclares, G, Tran, LC, de Sanctis, L, Elli, F, et al.. Genetic and epigenetic defects at the gnas locus lead to distinct patterns of skeletal growth but similar early-onset obesity. J Bone Miner Res 2018;33:1480–8. https://doi.org/10.1002/jbmr.3450.Suche in Google Scholar PubMed PubMed Central

Received: 2023-10-12
Accepted: 2024-01-03
Published Online: 2024-02-05
Published in Print: 2024-03-25

© 2024 Walter de Gruyter GmbH, Berlin/Boston

Heruntergeladen am 9.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2023-0454/pdf
Button zum nach oben scrollen